Improved assays for xenosensor activation based on reverse transfection

Area of Science:

• Pharmacology
• Biotechnology
• Drug Metabolism

Background:

• Receptor-dependent mechanisms regulate drug metabolism, influencing cytochrome P450 enzyme induction.
• Receptor-based reporter assays are crucial for early drug development and mechanistic studies.
• Conventional transfection methods can introduce variability and require multiple steps.

Purpose of the Study:

• To develop and validate a novel reverse transfection system for activation assays of human xenosensors.
• To improve the reproducibility and efficiency of assays for predicting drug-induced CYP enzyme activity.
• To provide a streamlined method for evaluating species differences and conducting mechanistic studies in drug development.

Main Methods:

• A reverse transfection system utilizing stable DNA/carrier complexes on culture plates.
• Activation assays for human aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR), and pregnane X receptor (PXR).
• Formal validation of the assay system with Z' factors exceeding 0.5.

Main Results:

• The reverse transfection system demonstrated long-term stability and uniformity.
• The assay format avoided multiple stages and reduced inherent variations compared to conventional methods.
• The system proved to be streamlined, reproducible, and formally validated.

Conclusions:

• The novel reverse transfection system offers a robust and efficient method for studying xenosensor activation.
• This system is valuable for predicting cytochrome P450 induction and evaluating species differences in early drug development.
• The validated assay is expected to be widely applicable in various aspects of preclinical drug safety assessment.